CHRS
Coherus Oncology: Revolutionizing Cancer Treatment with Innovative Strategies
Coherus Oncology, Inc. recently concluded its fourth quarter and 2025 year-end earnings conference call, providing insight into the company's transformative journey to become a leading innovative oncology company. Under the strategic leadership of Chief Executive Officer Denny Lanfear, Coherus has successfully completed its transformation by divesting its biosimilar